Within half a month, 4 new Chinese medicine drugs were approved for marketing

In recent years, the important value of traditional Chinese medicine is becoming more and more recognized and accepted
by Chinese people and even the world.
At the same time, the research and development of new traditional Chinese medicine drugs has also ushered in a new period of development, and more and more new drugs are emerging
.
Data show that in 2021, more than ten innovative traditional Chinese medicine drugs, such as lung cleansing and detoxification granules, kidney nourishing and calming tablets, Yiqi tongqiao pills, and Yinqiao clear heat tablets, were intensively approved for marketing
.
In 2022, CDE data statistics show that in the first three quarters alone, a total of 45 new Chinese medicine drug acceptance numbers have been undertaken
.
Among them, it is worth mentioning that in the last half of 2022, 4 new Chinese medicine drugs were approved for marketing
one after another.
Anbang Pharmaceutical Qi Gel Modulation Granules Approved for Marketing Recently, the State Medical Products Administration approved the listing of the new compound preparation of traditional Chinese medicine Qi Glue Modulated Granules declared by Hunan Anbang Pharmaceutical Co.

, Ltd.
The drug is composed of 9 flavored medicines such as astragalus, ejiao, codonopsis, white peony, etc.
, which has the effect of invigorating qi and replenishing blood, stopping bleeding and regulating menstruation, and is used for the prolongation of menstruation caused by the upper ring, and the differentiation of traditional Chinese medicine is the two deficiency of
qi and blood.
The drug has carried out multi-center, randomized, double-blind, marketed parallel controlled clinical trials of traditional Chinese
medicines.
The results of clinical trial studies showed that the recovery rate and the pronounced rate were 31.
82% and 63.
64% in the experimental group and 12.
00% and 38.
00% in the control group, respectively.

Kangbei Huangshu Sunflower Total Flavonoid Extract and Oral Patch Obtained Drug Registration Certificate On December 22, Kangbei Pharmaceutical Co.
, Ltd.
, a wholly-owned subsidiary of the company, obtained the drug registration certificate
of traditional Chinese medicine innovative drug Huangshu Sunflower Total Flavonoid Extract and Huangshu Sunflower Total Flavonoid Oral Patch.
As an innovative drug of traditional Chinese medicine in the original registration classification of class 5 (now registered classification of Chinese medicine class 1.
2), the total flavonoid extract of sunflower is an effective part extracted from the single-flavor drug Huangshu sunflower flower, and the total flavonoid oral patch of marshmallow flower is the first double-layer oral patch of traditional Chinese medicine in China
.
According to the Combe press release, the function of the total flavonoid oral patch of Huangshu sunflower is to clear the heart and release heat
.
It is used for mild recurrent oral ulcers caused by cardiosplenic fever, and the symptoms are oral mucosal ulcers, local redness, swelling, burning pain, etc
.
The approval of the production and marketing of total flavonoid extract and oral patch of sunflower is an important step for Kangbei to focus on the development of traditional Chinese medicine health business and build the main platform of traditional Chinese medicine health industry in Zhejiang Province, which is expected to play an important role
in enriching its product line and enhancing market competitiveness.
Kangyuan Pharmaceutical's Class 3.
1 New Traditional Chinese Medicine Linggui Shugan Granules Launched On December 28, the State Medical Products Administration approved the listing
of Kangyuan Pharmaceutical's Class 3.
1 new drug Linggui Shugan Granules.
Class 3 new Chinese medicine drugs, namely ancient classic Chinese medicine compound preparations
.
Ancient classical formulas refer to formulas recorded in ancient Chinese medicine texts that comply with the provisions of the Chinese Medicine Law and are still widely used, have precise curative effects, and have obvious characteristics and advantages
.
Ancient classic Chinese medicine compound preparation refers to the traditional Chinese medicine compound preparation derived from ancient classic formulas, and Linggui Shugan granules are the first Chinese medicine compound preparations
approved for marketing according to the catalogue of ancient classic formulas.
The industry expects that the approval of this drug will help promote the wider use of ancient classical formulas in clinical practice, and help improve the clinical service level of traditional Chinese medicine and the convenience of patients
' medication.
Huachun Pharmaceutical's Class 1.
1 innovative drug Ginseng Kidney Capsules was approved for marketing On December 29, the State Medical Products Administration approved the listing
of Ginseng Kidney Capsules, a Class 1.
1 innovative drug of traditional Chinese medicine declared by Xinjiang Huachun Biopharmaceutical.
The drug invigorates qi, nourishes yin, tonifies kidney, and is suitable for mild and moderate depression, and Chinese medicine distinguishes between qi and yin deficiency and kidney qi deficiency
.
At present, a randomized, double-blind, placebo-controlled multi-center clinical trial has been carried out, and the results of the clinical trial show that the difference between the main efficacy indicator HAMD-17 score and the baseline is better than that of the placebo group
.
The launch of the drug will provide a new treatment option
for patients with depression.
Disclaimer: Under no circumstances does the information or opinions expressed herein constitute investment advice
to anyone.